| Literature DB >> 34948953 |
Anna Starzyńska1, Magdalena Kaczoruk-Wieremczuk1, Michele Antonio Lopez2, Pier Carmine Passarelli3, Paulina Adamska1.
Abstract
Surgical removal of impacted mandibular third molars constitutes one of the most frequently performed procedures within oral surgery. This surgery procedure is associated with many post-operative complications. Advanced platelet-rich fibrin (A-PRF) belongs to the second generation of platelet concentrates and is rich in numerous growth factors. The aim of this study was to assess the influence of A-PRF on selected clinical features following the surgical removal of impacted mandibular third molars. The research was conducted on 100 generally healthy patients, who underwent a lower third molar odontectomy in Department of Oral Surgery, Medical University of Gdańsk, Poland, between 2018 and 2019. The research group consisted of 50 patients (immediate A-PRF socket filling) and control group (50 patients without A-PRF socket filling). During the study, the following clinical features were assessed: pain (visual analog scale), analgesics intake, the presence of trismus, edema, hematomas within the surrounding tissues (e.g., cheek), prevalence of pyrexia, dry socket, secondary bleeding, presence of hematomas, skin warmth in the post-operative area, and bleeding time observed by the patient were analyzed on the 3rd, 7th, and 14th day after the procedure. There was a significant association between A-PRF socket filling and pain intensity, the analgesics intake, trismus, and edema on the 3rd and the 7th day (p < 0.05). The presence of hematomas and skin warmth on the 3rd day after the surgery (p < 0.05) were also statistically associated with A-PRF use. The study showed that in reducing the incidence of postoperative complications, A-PRF was more important than the position of the tooth or the duration of the procedure. The growth factors in A-PRF reduce postoperative complications, such as pain, trismus, edema, analgesics intake, presence of hematomas, and skin warmth, after mandibular wisdom teeth odontectomy.Entities:
Keywords: A-PRF; advanced platelet-rich fibrin; growth factors; impacted teeth; third molar extraction; wound healing
Mesh:
Year: 2021 PMID: 34948953 PMCID: PMC8702191 DOI: 10.3390/ijerph182413343
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1(A) Removing A-PRF clot from the tube; (B) A-PRF clots after remove from the tubes; (C) A-PRF corks preparation; (D) A-PRF application.
Figure 2The location of the reference points within the skin and a schematic representation of the distance measurements between them.
Characteristic of patients and clinical features (SD—standard deviation; p—p value).
| Clinical and Pathological Patient Characteristics | Control Group | Study Group |
| ||
|---|---|---|---|---|---|
| Age Median ± SD (Range) [Years] | 28.5 ± 5.7 (18–42) | 29.3 ± 7.4 (19–47) | - | ||
| Gender | Female | 32 (64%) | 33 (66%) | 0.216 | |
| Male | 18 (36%) | 17 (34%) | |||
| Grade of tooth retention | Complete retention | 9 (18%) | 3 (6%) | 0.003 | |
| Partial retention | 41 (82%) | 47 (94%) | |||
| Tooth position | Vertical | 25 (50%) | 33 (66%) | 0.839 | |
| Horizontal | 25 (50%) | 17 (34%) | |||
| Time of surgery procedure | <30 min | 41 (82%) | 40 (80%) | 0.114 | |
| ≥30 min | 9 (19%) | 10 (20%) | |||
| Pain (VAS scale) | 3rd day | 0–3 | 11 (22%) | 42 (84%) | <0.001 |
| 4–6 | 25 (50%) | 8 (16%) | |||
| 7–10 | 14 (28%) | 0 (0%) | |||
| 7th day | 0–3 | 48 (96%) | 49 (98%) | <0.001 | |
| 4–6 | 2 (4%) | 1 (2%) | |||
| 7–10 | 0 (0%) | 0 (0%) | |||
| 14th day | 0–3 | 50 (100%) | 50 (100%) | >0.050 | |
| 4–6 | 0 (0%) | 0 (0%) | |||
| 7–10 | 0 (0%) | 0 (0%) | |||
| Painkillers intake | 3rd day | median (range) | 3 (0–4) doses | 2 (0–4) | <0.001 |
| 7th day | median (range) | 0 (0–2) | 0 (0–2) | 0.048 | |
| 14th day | median (range) | 0 (0) | 0 (0) | 1.000 | |
| Trismus | 3rd day | Lack of trismus | 5 (10%) | 23 (46%) | <0.001 |
| First grade | 13 (26%) | 22 (44%) | |||
| Second grade | 21 (42%) | 3 (6%) | |||
| Third grade | 11 (22%) | 1 (2%) | |||
| 7th day | Lack of trismus | 29 (58%) | 45 (90%) | <0.001 | |
| First grade | 18 (36%) | 5 (10%) | |||
| Second grade | 3 (6%) | 0 (%) | |||
| Third grade | 0 (%) | 0 (%) | |||
| 14th day | Lack of trismus | 50 (100% | 50 (100% | 0.495 | |
| First grade | 0 (%) | 0 (%) | |||
| Second grade | 0 (%) | 0 (%) | |||
| Third grade | 0 (%) | 0 (%) | |||
| Edema | Texture of edema | ||||
| 3rd day | Lack of edema | 4 (8%) | 12 (24%) | 0.006 | |
| Soft edema | 33 (66%) | 35 (70%) | |||
| Hard edema | 13 (26%) | 13 (26%) | |||
| 7th day | Lack of edema | 24 (48%) | 45 (90%) | <0.001 | |
| Soft edema | 18 (36%) | 5 (10%) | |||
| Hard edema | 8 (16%) | 0 (0%) | |||
| 14th day | Lack of edema | 47 (94%) | 50 (100%) | 0.242 | |
| Soft edema | 1 (2%) | 0 (0%) | |||
| Hard edema | 2 (4%) | 0 (0%) | |||
| Size of edema | |||||
| 3rd day | Lack of edema | 4 (8%) | 12 (24%) | <0.001 | |
| Small edema | 17 (34%) | 35 (70%) | |||
| Medium edema | 27 (54%) | 3 (6%) | |||
| Large edema | 2 (4%) | 0 (0%) | |||
| 7th day | Lack of edema | 24 (48%) | 45 (90%) | <0.001 | |
| Small edema | 25 (50%) | 5 (10%) | |||
| Medium edema | 1 (2%) | 0 (0%) | |||
| Large edema | 0 (0%) | 0 (0%) | |||
| 14th day | Lack of edema | 47 (94%) | 50 (100%) | 0.242 | |
| Small edema | 3 (6%) | 0 (0%) | |||
| Medium edema | 0 (0%) | 0 (0%) | |||
| Large edema | 0 (0%) | 0 (0%) | |||
| Bleeding time | <30 min | 2 (4%) | 21 (42%) | <0.001 | |
| Up to 1 h | 36 (72%) | 22 (44%) | |||
| 2–3 h | 6 (12%) | 5 (10%) | |||
| 4–6 h | 6 (12%) | 2 (4%) | |||
| Hematoma | 3rd day | Lack of hematoma | 35 (70%) | 50 (100%) | <0.001 |
| Buccal hematoma | 9 (18%) | 0 (0%) | |||
| Submandible hematoma | 5 (10%) | 0 (0%) | |||
| Neck hematoma | 1 (2%) | 0 (0%) | |||
| 7th day | Lack of hematoma | 42 (84%) | 47 (94%) | 0.453 | |
| Buccal hematoma | 3 (6%) | 1 (2%) | |||
| Submandible hematoma | 3 (6%) | 1 (2%) | |||
| Neck hematoma | 2 (4%) | 1 (2%) | |||
| 14th day | Lack of hematoma | 50 (100%) | 50 (100%) | 1.000 | |
| Buccal hematoma | 0 (0%) | 0 (0%) | |||
| Submandible hematoma | 0 (0%) | 0 (0%) | |||
| Neck hematoma | 0 (0%) | 0 (0%) | |||
| Secondary bleeding | 3rd day | No | 48 (96%) | 50 (100%) | 0.495 |
| Yes | 2 (4%) | 0 (0%) | |||
| 7th day | No | 50 (100%) | 50 (100%) | 1.000 | |
| Yes | 0 (0%) | 0 (0%) | |||
| 14th day | No | 50 (100%) | 50 (100%) | 1.000 | |
| Yes | 0 (0%) | 0 (0%) | |||
| Dry socket | 3rd day | No | 49 (98%) | 50 (100%) | 1.000 |
| Yes | 1 (2%) | 0 (0%) | |||
| 7th day | No | 49 (98%) | 49 (98%) | 1.000 | |
| Yes | 1 (2%) | 1 (2%) | |||
| 14th day | No | 50 (100%) | 50 (100%) | 1.000 | |
| Yes | 0 (0%) | 0 (0%) | |||
| Pyrexia | 3rd day | No | 42 (84%) | 45 (90%) | 0.552 |
| Yes | 8 (16%) | 5 (10%) | |||
| 7th day | No | 49 (98%) | 50 (100%) | 1.000 | |
| Yes | 1 (2%) | 0 (0%) | |||
| 14th day | No | 50 (100%) | 50 (100%) | 1.000 | |
| Yes | 0 (0%) | 0 (0%) | |||
| Skin warmth | 3rd day | No | 37 (74%) | 47 (94%) | 0.014 |
| Yes | 13 (26%) | 3 (6%) | |||
| 7th day | No | 50 (100%) | 50 (100%) | 1.000 | |
| Yes | 0 (0%) | 0 (0%) | |||
| 14th day | No | 50 (100%) | 50 (100%) | 1.000 | |
| Yes | 0 (0%) | 0 (0%) | |||
Figure 3Time-dependent variability of pain intensity in the control and study groups.
Figure 4Time-dependent variability in the intake of painkillers in the control and study groups.